For people with type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which ...

For individuals with Type 1 diabetes, the risk of hypoglycemia, dangerously low blood sugar, is a constant concern. When ...

For individuals with type 1 diabetes – an autoimmune condition – maintaining stable blood sugar is a constant challenge.

MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...

US researchers have developed a tiny implantable device that automatically releases glucagon to prevent life-threatening low blood sugar in Type 1 diabetics, eliminating the need for emergency ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...